Animal Health Investment Europe in London

Our colleagues Cesar Carnicer, Alfonso Martín-Fontecha and Luisa De Arriba attended Animal Health Investment Europe in London.

Animal Health Investment Europe is a top level event that presents the most attractive investment opportunities in the field of animal and nutritional health.The event brings companies, financial investors and corporate strategy partners together from 38 countries all over the world.

To complement the investment fora, debates were organised at the highest level that tackled animal health industry market trends and dynamics for all species.

This event basically facilitates the creation of contacts. Participants could meet the most relevant people in the pharmaceutical industry and animal nutritional health field over the course of two days – from 200 new companies to leaders of 18 of the 20 most important animal health companies.

You may also be interested in

30 January, 2025

Syvac® EH Marker, the first and only DIVA vaccine against EHD, is now authorized in Belgium

Syva is pleased to announce that the FAMHP/FAGG has granted emergency use authorization for its marker (DIVA) vaccine against EHD in accordance with Article 110(2) of Regulation (EU) 2019/6 for use in cattle and deer.

Read more

24 January, 2025

Call for the 28th edition of the Syva Award International for the best doctoral thesis in Animal Health

We are pleased to remind you that the call for applications for the 28th Syva Award International is open until 18 February 2025. We also remind you that for two years now, the Syva Award International is no longer limited to Spanish candidates, but invites all doctoral students of any nationality who have submitted their thesis in animal health...

Read more

22 January, 2025

Syva receives a positive opinion for Syvazul BTV 3 vaccine from the CVMP of the European Medicines Agency (EMA).

On 15 January 2025, the Committee for Medicinal Products for Veterinary Use (CVMP) issued a positive opinion recommending the granting of a marketing authorization for Syvazul BTV 3 vaccine. This step forward marks an important milestone in the fight against Bluetongue, and Syva is proud to be at the forefront of this innovation.

Read more